Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

To make its patient-centric mission authentic, Ray Therapeutics organizes sessions for all employees, including technical staff in manufacturing (CMC), to meet and hear from patients. This initiative, sparked by an employee's request, bridges the gap between the conceptual 'patient' and a real person.

Related Insights

To embed customer obsession, Hostinger automates scheduling so every employee, regardless of role, conducts several face-to-face interviews with customers per quarter. This non-scalable, direct interaction provides golden insights and ensures product development is grounded in real-world user needs across different global markets.

To foster deep motivation, leaders must explicitly connect every employee's role, no matter how small, to the ultimate mission. Ger Brophy explains how showing a factory worker that the product they make is critical for a specific cancer treatment allows them to feel personal ownership of the patient impact.

To humanize R&D and maintain motivation, biotech leaders bring patients into the company. This practice directly connects scientists with the human impact of their work, grounding the entire team in their shared purpose, especially on difficult days.

A common failure in biotech is viewing patients solely as data sources rather than as human partners in the development process. This perspective leads to unnecessarily complex protocols with high patient burden. The most successful firms build relationships with patient advocacy groups and design trials that respect the patient's experience.

Standard retina clinics lack expertise in testing blind patients. Ray Therapeutics proactively built its own Vision Research and Assessment Institute two years before its trial to run natural history studies with low-vision experts. This allowed them to define appropriate endpoints and reduce data variability.

A former medic explains that hands-on patient care provides an irreplaceable perspective for executives. It grounds strategic decisions in the reality of the patient experience, which is crucial for communicating value to teams and investors and maintaining a patient-first culture.

To bridge the psychological gap between direct patient care and the abstract world of pharma R&D, a former clinician visualizes data points not as numbers, but as the real people he once treated. This mental model keeps the patient as the 'North Star' in all decisions.

A crucial piece of advice for biotech founders is to interact with patients as early as possible. This 'patient first' approach helps uncover unmet needs in their treatment journey, providing a more powerful and differentiated perspective than focusing solely on the scientific or commercial landscape.

To build deep customer empathy, embed every new employee—regardless of role or seniority—with a real customer for several days. Their sole task is to solve one real problem, creating an immediate, visceral connection to the company's purpose.

CEO Paul Bresge's entry into biotech was directly triggered by his 15-year-old daughter being diagnosed with a blinding disease and told there was no hope. This personal stake deeply informs the company's patient-first culture and strategic direction, moving beyond a purely commercial motivation.